Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

45.9%

34 terminated/withdrawn out of 74 trials

Success Rate

46.0%

-40.5% vs industry average

Late-Stage Pipeline

12%

9 trials in Phase 3/4

Results Transparency

62%

18 of 29 completed trials have results

Key Signals

5 recruiting18 with results17 terminated17 withdrawn

Enrollment Performance

Analytics

N/A

28(60.9%)

Phase 4

7(15.2%)

Phase 2

6(13.0%)

Phase 1

2(4.3%)

Phase 3

2(4.3%)

Early Phase 1

1(2.2%)

46Total

N/A(28)

Phase 4(7)

Phase 2(6)

Phase 1(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (74)

Showing 20 of 74 trials

NCT02076113Not ApplicableActive Not Recruiting

Cervical Spondylotic Myelopathy Surgical Trial

Role: lead

NCT00871754Active Not Recruiting

Molecular Analysis Of Bladder Cancer

Role: lead

NCT00872495Recruiting

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Role: lead

NCT06868589Phase 4Recruiting

Reducing Pain With Methadone and Ketamine in Liver Transplant

Role: lead

NCT04844970Phase 2Terminated

Anamorelin Study for Advanced Pancreatic Cancer

Role: lead

NCT05966038Recruiting

ALS/MND Natural History Study Data Repository

Role: collaborator

NCT03696199Phase 4Recruiting

Randomized Controlled Trial for Ankle Fracture Pain Control

Role: lead

NCT03737370Phase 1Completed

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Role: collaborator

NCT03570801Not ApplicableActive Not Recruiting

SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion

Role: lead

NCT07187063Not ApplicableRecruiting

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

Role: lead

NCT00868803Active Not Recruiting

Aberrant Gene Expression Prostate Carcinoma

Role: lead

NCT03960008Phase 3Terminated

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

Role: lead

NCT05993195Completed

Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion

Role: lead

NCT02182687Phase 2Completed

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant

Role: lead

NCT05994404Completed

Cervical Spondylotic Myelopathy - Cost Observational Surgical Trial

Role: lead

NCT00872950Unknown

3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

Role: lead

NCT01813370Completed

A Registry for Patients Treated on the Clinical Trial TAX 3503

Role: collaborator

NCT02779803Withdrawn

STAMCAR: A Prospective EC-IC Bypass Registry

Role: lead

NCT04262947Not ApplicableTerminated

Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

Role: lead

NCT04647643Completed

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease

Role: lead